Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7Kidney Neoplasms 2Urolithiasis 1Stomatitis 1Pneumoperitoneum 1Neoplasm Metastasis 1Lower Urinary Tract Symptoms 1Invasive Bladder Cancer 1Hydronephrosis 1Gastrointestinal Stromal Tumors 1Castrate-Resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 92Gemcitabine 56Nivolumab 50Cisplatin 39atezolizumab 37Carboplatin 30avelumab 29enfortumab vedotin 26Docetaxel 23Magnetic Resonance Spectroscopy 19Mitomycin 17Ipilimumab 17Paclitaxel 16Specimen Handling 14durvalumab 11toripalimab 10sacituzumab govitecan 10Pemetrexed 10cabozantinib 9Taxes 8vinflunine 7Cyclophosphamide 7tislelizumab 6Injections 6Bevacizumab 6pemigatinib 5fludarabine 5disitamab vedotin 5Standard of Care 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × Sodium Chloride × Genitourinary × Clear all
NCT03794102 2019-01-04

Water Versus Saline as Irrigation Fluid for Ureteroscopy

Emory University

Phase NA Completed
150 enrolled
Genitourinary

Carcinoma, Transitional Cell, Hydronephrosis, Urolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡